Menu

Aytu BioPharma, Inc. AYTU

Full chart Compare
Set alert

Price alert · AYTU

All alert types
1.81 USD 0.00 (+0.00%)

At closeNov 11, 2026, 4:00 PM EST

1.81 0.00 0.00%

After hours · Nov 11, 4:00 PM ET

1.81 Day range 1.90
1.75 52-week range 3.07
YTD
-30.38%
1 year
-13.81%

Revenue & Expenses

Income Tax Benefit → Expenses: $21.00KExpenses → Selling, General & Admin: $42.64MExpenses → Other Operating Expenses: $2.49MExpenses → Other Expenses: $5.96MGross Profit → Expenses: $36.82MRevenue → Gross Profit: $36.82MRevenue → Cost of Revenue: $20.75MNet Loss → Expenses: $14.25MIncome Tax Benefit$21.00KGross Profit$36.82MNet Loss$14.25MCost of Revenue$20.75MExpenses$51.09MSelling, General & Admin$42.64MOther Operating Expenses$2.49MOther Expenses$5.96MRevenue$57.57M

Latest period ending Jun 30, 2026 · select a line to chart its full history

AYTU annual income statement
Fiscal yearFY 2026 Jun 30, 2026FY 2025 Jun 30, 2025FY 2024 Jun 30, 2024FY 2023 Jun 30, 2023FY 2022 Jun 30, 2022
57.57M66.38M65.18M73.80M96.67M
36.82M45.83M49.05M52.23M52.28M
-8.31M-7.83M-1.59M-7.94M-111.56M
-14.25M-13.56M-15.84M-17.05M-108.78M
-1.16-2.16-2.86-5.11-74.01
AYTU annual balance sheet
Fiscal yearFY 2026 Jun 30, 2026FY 2025 Jun 30, 2025FY 2024 Jun 30, 2024FY 2023 Jun 30, 2023FY 2022 Jun 30, 2022
26.31M30.95M20.01M22.98M19.36M
105.01M124.18M118.09M136.46M137.62M
69.73M105.21M90.38M97.11M93.31M
17.03M21.82M15.13M16.36M18.19M
35.27M18.97M27.72M39.36M44.31M
AYTU annual cash flow
Fiscal yearFY 2026 Jun 30, 2026FY 2025 Jun 30, 2025FY 2024 Jun 30, 2024FY 2023 Jun 30, 2023FY 2022 Jun 30, 2022
3.28M-1.94M-1.39M-5.13M-28.82M
-29.00K-2.56M-329.00K-117.00K-3.25M
-7.90M15.44M-1.26M8.87M1.53M
-29.00K440.00K-329.00K00
-4.64M10.95M-2.98M3.63M-30.54M